Comparison of p63 and p73 expression in benign and malignant salivary gland lesions
- PMID: 16021638
- DOI: 10.1002/hed.20227
Comparison of p63 and p73 expression in benign and malignant salivary gland lesions
Abstract
Background: The p63 and p73 genes are members of the p53 family and play an important role in stem cell identity and cellular differentiation and are expressed in basal and myoepithelial cells. In this study, we examined the expression of p63 and p73 in 50 various benign salivary gland lesions and 45 malignant salivary gland tumors.
Methods: The 95 salivary gland tumors were selected from the archives of the Department of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania. Sectioned formalin-fixed paraffin-embedded tissue cut at 3 mum was immunostained with antibodies that recognize all isozymes of p63 and p73 and evaluated with respect to percentage of positive cells and localization.
Results: In benign lesions, p63 and p73 nuclear reactivity was seen in 46 (92%) of 50 and 47 (94%) of 50 cases, respectively. In malignant tumors, p63 and p73 were seen in 34 (76%) of 45 and 40 (89%) of 45 cases, respectively. A significant difference between p63 and p73 positivity was only seen in adenoid cystic carcinomas (p = .006). Also, p73 was found in tumors with minimal basal/myoepithelial differentiation.
Conclusions: Hence, p63 and p73 expression is retained in both benign and malignant salivary gland tumors with basaloid or myoepithelial differentiation. Hence, p63 seems to be a more specific marker of myoepithelial differentiation than p73.
Copyright 2005 Wiley Periodicals, Inc.
Similar articles
-
Expression profiles of p53, p63, and p73 in benign salivary gland tumors.Virchows Arch. 2002 Nov;441(5):428-36. doi: 10.1007/s00428-002-0705-y. Epub 2002 Sep 11. Virchows Arch. 2002. PMID: 12447671
-
Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 May;97(5):613-9. doi: 10.1016/S1079210403005742. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004. PMID: 15153875
-
p63 expression in salivary gland tumors: role of DeltaNp73L in neoplastic transformation.Int J Surg Pathol. 2005 Oct;13(4):329-35. doi: 10.1177/106689690501300404. Int J Surg Pathol. 2005. PMID: 16273188
-
p53, p63 and p73--solos, alliances and feuds among family members.Biochim Biophys Acta. 2001 Dec 28;1552(2):47-59. doi: 10.1016/s0304-419x(01)00036-1. Biochim Biophys Acta. 2001. PMID: 11825686 Review.
-
p63 and p73: roles in development and tumor formation.Mol Cancer Res. 2004 Jul;2(7):371-86. Mol Cancer Res. 2004. PMID: 15280445 Review.
Cited by
-
2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors.Int J Mol Sci. 2021 Jun 24;22(13):6771. doi: 10.3390/ijms22136771. Int J Mol Sci. 2021. PMID: 34202474 Free PMC article. Review.
-
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors.Biomark Res. 2021 Jan 25;9(1):7. doi: 10.1186/s40364-021-00260-5. Biomark Res. 2021. PMID: 33494829 Free PMC article.
-
Diagnostic Utility of Immunohistochemical Expressions of IMP3 Versus DOG1 and p63 in Salivary Gland Tumors.Turk Patoloji Derg. 2020;36(3):227-236. doi: 10.5146/tjpath.2020.01496. Turk Patoloji Derg. 2020. PMID: 32692399 Free PMC article.
-
Rapid development of salivary gland carcinomas upon conditional expression of K-ras driven by the cytokeratin 5 promoter.Am J Pathol. 2006 May;168(5):1654-65. doi: 10.2353/ajpath.2006.050847. Am J Pathol. 2006. PMID: 16651631 Free PMC article.
-
Basaloid/blue salivary gland tumors.Mod Pathol. 2017 Jan;30(s1):S84-S95. doi: 10.1038/modpathol.2016.190. Mod Pathol. 2017. PMID: 28060371 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous